Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, William Rastetter, Richard Lingard, John DelliSanti

BIOCOM, a Southern California life sciences trade association, said this week that it has named eight new members to its board of directors. Invitrogen Chairman and CEO Greg Lucier is chairman of the board for 2007-2008.
 
Among the other board members is William Rastetter, who is a venture partner for Venrock Associates, a former chairman of BIOCOM, and currently serves as chairman of the board of Illumina.
 

 
DeltaDot this week said it has named Richard Lingard vice president of sales. Lingard previously was a director of strategic alliances at Invitrogen, vice president of business development at Argenta Discovery, director of business development at Inpharmatics, and was a sales director at Genomica. Lingard also served in business positions at Accelrys and at Merck.
 

 
Caliper Life Sciences has named John DelliSanti to the position of executive vice president and chief commercial officer. In this post he will lead Caliper’s worldwide sales, marketing, and services efforts.
 
DelliSanti joins Caliper from Invitrogen, where he led the Americas commercial operations. He has also held positions at Accelrys, Wyeth Pharmaceuticals, and Hitachi Instruments.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.